CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

TSX:CHR • CA17040T8885

24.74 CAD
-0.4 (-1.59%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, CHR scores 4 out of 10 in our fundamental rating. CHR was compared to 6 industry peers in the Passenger Airlines industry. CHR has an average financial health and profitability rating. CHR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • CHR had positive earnings in the past year.
  • CHR had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
  • Of the past 5 years CHR 4 years had a positive operating cash flow.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

  • CHR has a Return On Assets of -2.62%. This is comparable to the rest of the industry: CHR outperforms 50.00% of its industry peers.
  • CHR has a Return On Equity of -6.31%. This is in the better half of the industry: CHR outperforms 66.67% of its industry peers.
  • CHR's Return On Invested Capital of 6.40% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 4.97%.
  • The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

  • CHR has a Operating Margin of 6.81%. This is amongst the best in the industry. CHR outperforms 83.33% of its industry peers.
  • CHR's Operating Margin has declined in the last couple of years.
  • CHR has a better Gross Margin (65.68%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • CHR has an Altman-Z score of 0.96. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
  • CHR has a Altman-Z score (0.96) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
  • CHR has a better Debt to FCF ratio (10.63) than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CHR (0.50) is better than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.96
ROIC/WACC0.75
WACC8.48%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CHR (1.22) is better than 66.67% of its industry peers.
  • A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
  • The Quick ratio of CHR (0.63) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.94% over the past year.
  • CHR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.51% yearly.
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.33%

3.2 Future

  • CHR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.34% yearly.
  • The Revenue is expected to decrease by -2.14% on average over the next years.
EPS Next Y-16.67%
EPS Next 2Y-3.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.59%
Revenue Next 2Y-2.59%
Revenue Next 3Y-2.14%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.31, which indicates a very decent valuation of CHR.
  • Based on the Price/Earnings ratio, CHR is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.07. CHR is valued rather cheaply when compared to this.
  • CHR is valuated correctly with a Price/Forward Earnings ratio of 12.37.
  • 83.33% of the companies in the same industry are more expensive than CHR, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.05. CHR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.31
Fwd PE 12.37
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 83.33% of the companies in the same industry are more expensive than CHR, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CHR is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.83
EV/EBITDA 4.26
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • A cheap valuation may be justified as CHR's earnings are expected to decrease with -3.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.34%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • CHR has a Yearly Dividend Yield of 1.43%. Purely for dividend investing, there may be better candidates out there.
  • CHR's Dividend Yield is a higher than the industry average which is at 0.90.
  • CHR's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

  • On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
  • CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 1 2 3

5.3 Sustainability

  • The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
DP-5.89%
EPS Next 2Y-3.34%
EPS Next 3YN/A
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

CHORUS AVIATION INC

TSX:CHR (2/27/2026, 7:00:00 PM)

24.74

-0.4 (-1.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap579.41M
Revenue(TTM)N/A
Net Income(TTM)-34.96M
Analysts78.18
Price Target31.18 (26.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)2.39%
PT rev (3m)3.05%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)2.65%
EPS NY rev (1m)0%
EPS NY rev (3m)5.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 10.31
Fwd PE 12.37
P/S 0.43
P/FCF 17.83
P/OCF 8.14
P/B 1.05
P/tB 1.06
EV/EBITDA 4.26
EPS(TTM)2.4
EY9.7%
EPS(NY)2
Fwd EY8.08%
FCF(TTM)1.39
FCFY5.61%
OCF(TTM)3.04
OCFY12.29%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.75
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.96
F-Score6
WACC8.48%
ROIC/WACC0.75
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
EPS Next Y-16.67%
EPS Next 2Y-3.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.33%
Revenue Next Year-4.59%
Revenue Next 2Y-2.59%
Revenue Next 3Y-2.14%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.94%
EBIT Next 3Y16.24%
EBIT Next 5Y9.99%
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 8 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 10.31 and the Price/Book (PB) ratio is 1.05.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 5 / 10.